Parkinson's Disease - Dec 18, 2017 Edition

December 18, 2017     Parkinson's Disease     The latest Parkinson's disease news from News Medical

Tapeworm drug could provide new hope for patients with Parkinson's disease   Researchers at Cardiff University, in collaboration with the University of Dundee, have identified a drug molecule within a medicine used to treat tapeworm infections which could lead to new treatments for patients with Parkinson's disease.       Study reveals connection between restless sleep and Parkinson's disease   A study published in the neurological journal, The Lancet Neurology, has identified that patients with rapid eye movement sleep behavior disorder (RBD) have a dopamine deficiency in the brain and suffer from a form of brain inflammation. They are subjected to increased risks of developing dementia or Parkinson's disease as they grow older.

High-intensity exercise decreases worsening of motor symptoms in Parkinson's patients   High-intensity exercise three times a week is safe for individuals with early-stage Parkinson's disease and decreases worsening of motor symptoms, according to a new phase 2, multi-site trial led by University of Colorado Anschutz Medical Campus and Northwestern Medicine scientists.         Parkinson's progression delayed through high-intensity exercise, study says   A new phase 2, multi-site trial conducted at the Northwestern Medicine and University of Colorado School of Medicine suggests that for people with early-stage Parkinson's disease, high-intensity exercise three times a week is safe and can delay the worsening of motor symptoms.         Specialized physiotherapy provides many benefits for patients with Parkinson’s disease   Specialized ParkinsonNet physiotherapy leads to better care at lower costs. This is the conclusion of large-scale research conducted by the CZ healthcare insurance company and Radboudumc, who studied the medical claims declarations of over four thousand people with Parkinson's disease for a period of three years.

An Overview of Parkinson's Disease   This article briefly describes the proteins and various cellular processes that go wrong in Parkinson's disease such as neuroinflammation, oxidative stress, mitochondrial dysfunction and alpha-synuclein misfolding.       Researchers explore how toxic protein clusters linked to Parkinson's disrupt brain cells   Researchers have glimpsed how the toxic protein clusters that are associated with Parkinson's Disease disrupt the membranes of healthy brain cells, creating defects in the cell walls and eventually causing a series of events that induce neuronal death.       Tools for Detecting Neuroinflammation in Neurodegenerative Diseases   This article shows how the root cause of neurodegeneration is identified with a variety of neuroinflammation research tools to detect proinflammatory mediators, aggregated proteins and glia in Parkinson's and Alzheimer's diseases.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK